bmy 7378 and ah 11110a

bmy 7378 has been researched along with ah 11110a in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erami, C; Faber, JE; French, DM; Ho, JG; Zhang, H1
Farias-Rodríguez, VM; Gallardo-Ortíz, IA; Gómez-Zamudio, JH; Lázaro-Suárez, ML; Tanoue, A; Tsujimoto, G; Villalobos-Molina, R1
Asbun-Bojalil, J; Castillo-Henkel, C; Castillo-Hernández, MC; Cervantes-Cruz, J; Cruz-Domínguez, MP; Miliar-García, A; Montes-Cortés, DH; Reséndiz-Ramírez, AC; Villalobos-Molina, R1

Other Studies

3 other study(ies) available for bmy 7378 and ah 11110a

ArticleYear
Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 283, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angioplasty, Balloon; Animals; Carotid Artery Injuries; Cell Division; Idazoxan; Imines; Indoles; Male; Muscle, Smooth, Vascular; Norepinephrine; Oxathiins; Piperazines; Piperidines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Recurrence; Tunica Intima; Vasoconstrictor Agents

2002
Chloroethylclonidine reveals that alpha (1 A)-adrenoceptors mediate contraction in aorta of alpha (1 D)-adrenoceptor knockout mice.
    Autonomic & autacoid pharmacology, 2005, Volume: 25, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; Clonidine; Dose-Response Relationship, Drug; Imines; In Vitro Techniques; Mice; Mice, Knockout; Norepinephrine; Piperazines; Piperidines; Receptors, Adrenergic, alpha-1; Vasoconstriction; Vasoconstrictor Agents

2005
Evidence of alpha1-adrenoceptor functional changes in omental arteries of patients with end-stage renal disease.
    Autonomic & autacoid pharmacology, 2008, Volume: 28, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Arteries; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Imines; Kidney Failure, Chronic; Male; Middle Aged; Omentum; Phenylephrine; Piperazines; Piperidines; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstriction; Vasoconstrictor Agents

2008